Objective: The concept of compensatory turbinate hypertrophy (CTH) has found a frequent mention in research works. However, despite its clinical significance, there is a paucity in the research of regulatory mechanisms of CTH process at the cellular levels. The objective of this study is to assess the importance of apoptosis in the CTH process and understand nasal physiology.
Material and Methods: In total, 23 adults who underwent septoplasty and partial turbinectomy for the management of unilateral nasal septal deviations (NSD) and CTH were included in this study. Turbinectomy specimens were immunohistochemically evaluated using terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) stain and anti-human-activated pro-Caspase 3 monoclonal antibody stains. Percentages of apoptotic cells (apoptotic index [AI]) were determined at various cell types. The statistical analysis was based on the AI differences between the hypertrophic and non-hypertrophic turbinates of the same patient. A subgroup analysis was also performed to evaluate the effect of smoking on AIs.
Results: No cell type had statistically significant AI differences between the hypertrophic and non-hypertrophic turbinates. Vascular smooth muscle cells of the CTH side had slightly lower AIs although this trend was statistically not significant (Caspase 3, p = 0.066). No difference in AIs was detected at the other cell types. Similarly, no AI difference related to smoking could be observed.
Conclusions: Our results have not shown any significant differences among AIs of many cell types between opposite turbinates or between smokers and nonsmokers. Therefore, apoptosis has not found to be active as a mechanism of regulation for the CTH of adults with stable NSDs.
| Primary Language | English |
|---|---|
| Subjects | Otorhinolaryngology |
| Journal Section | Research Article |
| Authors | |
| Publication Date | April 1, 2021 |
| Published in Issue | Year 2021 Volume: 4 Issue: 1 |
You can find the current version of the Instructions to Authors at: https://www.eurjrhinol.org/en/instructions-to-authors-104
Starting on 2020, all content published in the journal is licensed under the Creative Commons Attribution-NonCommercial (CC BY-NC) 4.0 International
License which allows third parties to use the content for non-commercial purposes as long as they give credit to the original work. This license
allows for the content to be shared and adapted for non-commercial purposes, promoting the dissemination and use of the research published in
the journal.
The content published before 2020 was licensed under a traditional copyright, but the archive is still available for free access.